Michel Detheux
2019
In 2019, Michel Detheux earned a total compensation of $1.6M as Ph.D. Chief Executive Officer at iTeos Therapeutics.
Compensation breakdown
| Bonus | $149,000 |
|---|---|
| Non-Equity Incentive Plan | $154,000 |
| Option Awards | $601,200 |
| Salary | $459,949 |
| Other | $216,000 |
| Total | $1,580,149 |
Detheux received $601.2K in option awards, accounting for 38% of the total pay in 2019.
Detheux also received $149K in bonus, $154K in non-equity incentive plan, $459.9K in salary and $216K in other compensation.
Rankings
In 2019, Michel Detheux's compensation ranked 7,076th out of 13,971 executives tracked by ExecPay. In other words, Detheux earned more than 49.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,076 out of 13,971 | 49th |
Division Manufacturing | 2,718 out of 5,701 | 52nd |
Major group Chemicals And Allied Products | 1,004 out of 2,200 | 54th |
Industry group Drugs | 851 out of 1,886 | 55th |
Industry Biological Products, Except Diagnostic Substances | 201 out of 389 | 48th |
Source: SEC filing on May 5, 2021.
Detheux's colleagues
We found one more compensation record of an executive who worked with Michel Detheux at iTeos Therapeutics in 2019.
2019
Joanne Lager
iTeos Therapeutics
Chief Medical Officer
News
iTeos Therapeutics CEO Michel Detheux's 2023 pay falls 45% to $5.8M
April 25, 2024
iTeos Therapeutics CEO Michel Detheux's 2022 pay jumps 88% to $11M
April 27, 2023
iTeos Therapeutics CEO Michel Detheux's 2021 pay falls 67% to $5.6M
April 25, 2022
iTeos Therapeutics CEO Michel Detheux's 2020 pay jumps 964% to $17M
May 5, 2021